Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q425027> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Q425027 subject Q8808795.
- Q425027 subject Q8824871.
- Q425027 abstract "Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug. It is marketed as GLIMPER by Pharmanova Ltd., GLEAM by Franco Indian Pharmaceuticals,K-GLIM-1 by BLUE CROSS, Glucoryl by Alkem Lab PVT LTD , Amaryl by Sanofi-Aventis, GLIMPID by Ranbaxy Laboratories(Cardiovascular) and GLIMY by Dr.Reddy's Labs.It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.".
- Q425027 atcPrefix "A10".
- Q425027 atcSuffix "BB12".
- Q425027 bioavailability "100.0".
- Q425027 casNumber "93479-97-1".
- Q425027 chEBI "5383".
- Q425027 drugbank "DB00222".
- Q425027 fdaUniiCode "6KY687524K".
- Q425027 iupacName "3-ethyl-4-methyl-N-(4-[N-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide".
- Q425027 pubchem "3476".
- Q425027 thumbnail Glimepiride.svg?width=300.
- Q425027 wikiPageExternalLink serve?objId=213&objCls=DrugProperties.
- Q425027 wikiPageExternalLink glimepiride.htm.
- Q425027 wikiPageExternalLink amaryl_tablets_sanofi_aventis.html.
- Q425027 wikiPageWikiLink Q158205.
- Q425027 wikiPageWikiLink Q188724.
- Q425027 wikiPageWikiLink Q193572.
- Q425027 wikiPageWikiLink Q200656.
- Q425027 wikiPageWikiLink Q202758.
- Q425027 wikiPageWikiLink Q271993.
- Q425027 wikiPageWikiLink Q274515.
- Q425027 wikiPageWikiLink Q3025883.
- Q425027 wikiPageWikiLink Q3510429.
- Q425027 wikiPageWikiLink Q377214.
- Q425027 wikiPageWikiLink Q407431.
- Q425027 wikiPageWikiLink Q410400.
- Q425027 wikiPageWikiLink Q411398.
- Q425027 wikiPageWikiLink Q418776.
- Q425027 wikiPageWikiLink Q575062.
- Q425027 wikiPageWikiLink Q6431240.
- Q425027 wikiPageWikiLink Q665843.
- Q425027 wikiPageWikiLink Q8808795.
- Q425027 wikiPageWikiLink Q8824871.
- Q425027 wikiPageWikiLink Q900898.
- Q425027 wikiPageWikiLink Q908961.
- Q425027 atcPrefix "A10".
- Q425027 atcSuffix "BB12".
- Q425027 bioavailability "100.0".
- Q425027 casNumber "93479".
- Q425027 chebi "5383".
- Q425027 drugbank "DB00222".
- Q425027 iupacName "3".
- Q425027 pubchem "3476".
- Q425027 unii "6".
- Q425027 type ChemicalSubstance.
- Q425027 type Drug.
- Q425027 type ChemicalObject.
- Q425027 type Thing.
- Q425027 type Q8386.
- Q425027 comment "Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug. It is marketed as GLIMPER by Pharmanova Ltd., GLEAM by Franco Indian Pharmaceuticals,K-GLIM-1 by BLUE CROSS, Glucoryl by Alkem Lab PVT LTD , Amaryl by Sanofi-Aventis, GLIMPID by Ranbaxy Laboratories(Cardiovascular) and GLIMY by Dr.Reddy's Labs.It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.".
- Q425027 label "Glimepiride".
- Q425027 depiction Glimepiride.svg.